Igene Biotechnology Stock Today
Performance0 of 100
| Odds Of DistressOver 84
|
Igene Biotechnology has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of November 2024 and ending today, the 16th of December 2024. Click here to learn more.
Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland. IGENE BIOTECHNOLOGY operates under Agricultural Inputs classification in the United States and is traded on PNK Exchange. The company has 1.57 B outstanding shares. More on Igene Biotechnology
Igene Biotechnology cannot be verified against its exchange. It appears that Igene Biotechnology is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshIgene Pink Sheet Highlights
| Business Concentration | Materials, Chemicals, Agricultural Inputs, Basic Materials (View all Sectors) |
Igene Biotechnology [IGNE] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 10.96 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Igene Biotechnology's market, we take the total number of its shares issued and multiply it by Igene Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Igene Biotechnology conducts business under Chemicals sector and is part of Materials industry. The entity has 1.57 B outstanding shares.
Igene Biotechnology currently holds about 269.29 K in cash with (97.05 K) of positive cash flow from operations.
Check Igene Biotechnology Probability Of Bankruptcy
Igene Stock Against Markets
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Igene Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Other Information on Investing in Igene Pink Sheet
Igene Biotechnology financial ratios help investors to determine whether Igene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Igene with respect to the benefits of owning Igene Biotechnology security.